Intelligence for founders, operators, and investors building sustainable cannabis ventures.
SynBiotic SE, once one of the largest and most promising cannabis companies in Germany, has announced plans to file for insolvency and had its shares suspended on the Xetra and Frankfurt stock exchanges.
James Duckenfield, CEO of Glass Pharms®, examines what irradiation changes in medical cannabis flower, what it leaves behind, and why understanding microbial quality requires a closer look at the science.
Bedrocan’s Dutch entities have officially been declared bankrupt, leaving stocks of life-saving medicinal cannabis in the hands of court-appointed administrators who cannot release them.
Cannavigia, a leading compliance and seed-to-sale software provider for the European cannabis industry, today announced a partnership with Watter BV, a Dutch disinfection company with 18 years of experience and more than 500 clients across agriculture and industrial sectors.
Thousands of Dutch patients are facing a 10-month supply gap for medically essential Bedrocan products, including varieties clinicians consider irreplaceable for children with treatment-resistant epilepsy.
James Duckenfield, CEO of Glass Pharms®, dives into the responsibilities behind a medical cannabis brand and why pharmaceutical standards should matter more than marketing.
Irish active-ingredient manufacturer Dunbar Pharmaceuticals has launched the UK’s first plant-derived dronabinol oral spray, extending a pharma-grade THC line that reached specialist prescribers in capsule form in August.
Written by Dr Nickel Dittrich, Managing Director, GMPion When Asia-Pacific producers talk about Europe, the conversation usually starts in the grow room.
A Michigan breach-of-contract dispute between cultivator Hello Farms and Curaleaf Holdings has cracked open a fault line that runs beneath every cannabis contract in the US, opening the door to a ‘mutually assured destruction’ defence that cannot be closed.
